Results 11 to 20 of about 34,012 (206)
Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines [PDF]
Korean Journal of Pediatrics, 2014 The 7-valent pneumococcal protein conjugate vaccine (PCV7) has been shown to be highly efficacious against invasive pneumococcal diseases and effective against pneumonia and in reducing otitis media. The introduction of PCV7 has resulted in major changes
Hyunju Lee, Eun Hwa Choi, Hoan Jong Lee
doaj +3 more sources
Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies [PDF]
Vaccines, 2021 The importance of Streptococcus pneumoniae has been well established. These bacteria can colonize infants and adults without symptoms, but in some cases can spread, invade other tissues and cause disease with high morbidity and mortality. The development
Giuliana S. Oliveira +3 more
doaj +2 more sources
Microbiology Spectrum, 2019 Streptococcus pneumoniae is a Gram-Positive pathogen that is a major causative agent of pneumonia, otitis media, sepsis and meningitis across the world.
D. E. Briles +4 more
doaj +4 more sources
Uptake of Pneumococcal Vaccines Among U.S. Adults After 2022 Update to Recommendations [PDF]
AJPM FocusIntroduction: Updated recommendations for adult pneumococcal vaccination in the U.S. (publication date: January 27, 2022) incorporated 2 new vaccines (15- and 20-valent pneumococcal conjugate vaccines), removed 13-valent pneumococcal conjugate vaccine ...
Ahuva Averin, MPP +5 more
doaj +2 more sources
Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
Risk Management and Healthcare Policy, 2018 Ger T Rijkers,1,2 Laura IE Yousif,1 Simone MC Spoorenberg,3 Frans J van Overveld1 1Department of Science, University College Roosevelt, Middelburg, the Netherlands; 2Department of Medical Microbiology and Immunology, St. Antonius Hospital ...
Rijkers GT +3 more
doaj +3 more sources
Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines [PDF]
VaccinesPreviously, it was shown that intranasally (i.n.) administered Corynebacterium pseudodiphtheriticum 090104 (Cp) or CP-derived bacterium-like particles (BLPs) improve the immunogenicity of the pneumococcal conjugate vaccine (PCV).
Ramiro Ortiz Moyano +10 more
doaj +2 more sources
Attitudes towards influenza and pneumococcal vaccines in parents of asthmatic children during the COVID-19 pandemic. [PDF]
Pediatr Pulmonol, 2022 Özer M, Başkaya N, Bostancı İ.
europepmc +3 more sources
Биопрепараты: Профилактика, диагностика, лечение, 2021 Streptococcus pneumoniae infection is the most common cause of high morbidity and mortality among children under 5 years of age, immunocompromised people, and the elderly.
M. V. Savkina +6 more
doaj +1 more source
Recent progress in pneumococcal protein vaccines
Frontiers in Immunology, 2023 Pneumococcal infections continue to pose a significant global health concern, necessitating the development of effective vaccines. Despite the progress shown by pneumococcal polysaccharide and conjugate vaccines, their limited coverage and the emergence ...
Sha Li +4 more
doaj +1 more source
Postgraduate Medical Journal, 1997 Summary Streptococcus pneumoniae is a frequent cause of pneumonia and meningitis. This article looks at the pneumococcal vaccine, its uses, efficacy, and adverse effects and how vaccination may be improved. We also look at the role of the new conjugate vaccines.
K L, Hattotuwa, C R, Hind
openaire +2 more sources